Paydirt
RL
Insider

Robert Lechleider

Chief Medical Officer

Robert Lechleider (Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Immunome, Inc. (IMNM). The largest single filing was $1.2M of IMNM (55,000 sh across 3 lots, as filed), executed Jul 2.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.3M
shares × price, as filed
Last traded
Jul 2
Filed Jul 7

Median ADV $31.5M across their filed names

Open performance
Volume by month
$1.2M$622K$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · buys $150KJun 2026 · sells $1.1MJul 2026 · sells $1.2M
Buys $150K Sells $2.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
IMNM Immunome, Inc. IMNM · 1 buy · 2 sells 3 filings
Recent filings
IMNMSALE Immunome, Inc. View filing → $1.2M
55,000 sh across 3 lots
Exec Jul 2
Filed Jul 7 · 5:42 PM ET
IMNMSALE Immunome, Inc. View filing → $1.1M
55,000 sh across 2 lots
Exec Jun 25
Filed Jun 29 · 5:30 PM ET
IMNMPURCHASE Immunome, Inc. View filing → $150K
15,805 sh × $9.48
Exec Nov 21 2024
Filed Nov 25 2024 · 5:30 PM ET